-
Most Popular

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Why Is Altamira Therapeutics (CYTO) Stock Up 28% Today?
Altamira Therapeutics stock is rising higher on Friday with heavy trading of CYTO shares despite a lack of news from the company.
Why Is EnGene (ENGN) Stock Up 8% Today?
EnGene stock is climbing higher on Thursday as investors in ENGN celebrate the company going public through a SPAC merger.
TTOO Stock Alert: T2 Biosystems Regains Nasdaq Compliance
TTOO stock is back above $1 and is now officially in compliance with Nasdaq's minimum bid price requirement of $1.
Why Is Aldeyra Therapeutics (ALDX) Stock Up 40% Today?
Aldeyra Therapeutics stock is rising with heavy trading of ALDX shares after signing an exclusive option agreement with AbbVie.
CRSP Stock Alert: Can CRISPR Therapeutics Short Squeeze Higher?
CRSP stock is rallying after an FDA panel appeared to view CRISPR Therapeutics' sickle-cell anemia treatment as safe.
Why Is Mainz Biomed (MYNZ) Stock Moving Today?
Mainz Biomed stock is on the move Wednesday as investors in MYNZ react to results from a colorectal cancer screening test campaign.
Why Is Cellectis (CLLS) Stock Up 175% Today?
Cellectis stock is taking off on Wednesday as investors in CLLS react to a massive $245 million investment from AstraZeneca.
Why Is Cardio Diagnostics (CDIO) Stock Up 45% Today?
Although Cardio Diagnostics scored a major contract for its AI-driven heart disease test, CDIO stock faces a wall of worry.
CRSP Stock Halt: CRISPR Trading Halted Ahead of FDA Decision
Investors in CRISPR and CRSP stock have certainly been on a wild ride so far this year. Here's what investors need to watch right now.
Why Is SciSparc (SPRC) Stock Up 58% Today?
SciSparc stock is rising higher with heavy trading of SPRC shares after the company announced approval for a patent in Australia.
Why Is Sarepta Therapeutics (SRPT) Stock Down 47% Today?
Sarepta Therapeutics stock is dropping with heavy trading as SRPT investors take in the lackluster results from a Phase 3 clinical trial.